Previously, we have identified three Zn
2+ binding residues in an endogenous Zn
2+ bindingsite in the human dopamine transporter (hDAT):
193His in extracellular loop 2 (ECL 2),
375His at theexternal end of transmembrane segment (TM) 7, and
396Glu at the external end of TM 8. Here we havegenerated a series of artificial Zn
2+ binding sites in a domain situated around the external ends of TMs7 and 8 by taking advantage of the well-defined structural constraints for binding of the zinc(II) ion.Initially, we found that the Zn
2+-coordinating
193His in ECL 2 could be substituted with a histidine insertedat the
i - 4 position relative to
375His in TM 7. In this mutant (H193K/M371H), Zn
2+ potently inhibited[
3H]dopamine uptake with an IC
50 value of 7
M as compared to a value of 300
M for the control(H193K). These data are consistent with the presence of an
-helical configuration of TM 7. This inferencewas further corroborated by the observation that no increase in the apparent Zn
2+ affinity was observedfollowing introduction of histidines at the
i - 2,
i - 3, and
i - 5 positions. In contrast, introduction ofhistidines at positions
i + 2,
i + 3, and
i + 4 all resulted in potent inhibition of [
3H]dopamine uptake byZn
2+ (IC
50 = 3-32
M). These observations are inconsistent with continuation of the helix beyond position375 and indicate an approximate boundary between the end of the helix and the succeeding loop. Insummary, the data presented here provide new insight into the structure of a functionally important domainin the hDAT and illustrate how engineering of Zn
2+ binding sites can be a useful approach for probingboth secondary and tertiary structure relationships in membrane proteins of unknown structure.